132 related articles for article (PubMed ID: 37804410)
1. Correction to: Paeoniforin ameliorates cognitive impairment in Parkinson's disease via JNK/p53 signaling.
He ZQ; Huan PF; Wang L; He JC
Metab Brain Dis; 2024 Jan; 39(1):255-261. PubMed ID: 37804410
[No Abstract] [Full Text] [Related]
2. Paeoniflorin ameliorates cognitive impairment in Parkinson's disease via JNK/p53 signaling.
He ZQ; Huan PF; Wang L; He JC
Metab Brain Dis; 2022 Apr; 37(4):1057-1070. PubMed ID: 35230626
[TBL] [Abstract][Full Text] [Related]
3. Unfolded p53 as a Marker of Oxidative Stress in Mild Cognitive Impairment, Alzheimer's and Parkinson's Disease.
García S; Amor-Gutiérrez O; Palomares-Albarrán M; Toyos-Rodríguez C; Cuetos F; Martínez C; Costa-García A; Fernández-Sánchez MT; de la Escosura-Muñiz A; Novelli A
Curr Alzheimer Res; 2021; 18(9):695-700. PubMed ID: 34789127
[TBL] [Abstract][Full Text] [Related]
4. Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease.
Schulz J; Pagano G; Fernández Bonfante JA; Wilson H; Politis M
Brain; 2018 May; 141(5):1501-1516. PubMed ID: 29701787
[TBL] [Abstract][Full Text] [Related]
5. Treadmill exercise ameliorates dopaminergic neuronal loss through suppressing microglial activation in Parkinson's disease mice.
Sung YH; Kim SC; Hong HP; Park CY; Shin MS; Kim CJ; Seo JH; Kim DY; Kim DJ; Cho HJ
Life Sci; 2012 Dec; 91(25-26):1309-16. PubMed ID: 23069581
[TBL] [Abstract][Full Text] [Related]
6. Ophthalmologic problems correlates with cognitive impairment in patients with Parkinson's disease.
Zhang C; Wu QQ; Hou Y; Wang Q; Zhang GJ; Zhao WB; Wang X; Wang H; Li WG
Front Neurosci; 2022; 16():928980. PubMed ID: 36278010
[TBL] [Abstract][Full Text] [Related]
7. Mild Cognitive Impairment in Parkinson's Disease-What Is It?
Weil RS; Costantini AA; Schrag AE
Curr Neurol Neurosci Rep; 2018 Mar; 18(4):17. PubMed ID: 29525906
[TBL] [Abstract][Full Text] [Related]
8. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.
Litvan I; Aarsland D; Adler CH; Goldman JG; Kulisevsky J; Mollenhauer B; Rodriguez-Oroz MC; Tröster AI; Weintraub D
Mov Disord; 2011 Aug; 26(10):1814-24. PubMed ID: 21661055
[TBL] [Abstract][Full Text] [Related]
9. Effect of cerebral small vessel disease on cognitive impairment in Parkinson's disease: a systematic review and meta-analysis.
Wan H; Wang G; Liu Q; Wang Y
Ann Transl Med; 2022 Mar; 10(6):288. PubMed ID: 35433969
[TBL] [Abstract][Full Text] [Related]
10. Possible role of glial cell line-derived neurotrophic factor for predicting cognitive impairment in Parkinson's disease: a case-control study.
Shi MY; Ma CC; Chen FF; Zhou XY; Li X; Tang CX; Zhang L; Gao DS
Neural Regen Res; 2021 May; 16(5):885-892. PubMed ID: 33229724
[TBL] [Abstract][Full Text] [Related]
11. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
[TBL] [Abstract][Full Text] [Related]
12. Resting-state fMRI in Parkinson's disease patients with cognitive impairment: A meta-analysis.
Wolters AF; van de Weijer SCF; Leentjens AFG; Duits AA; Jacobs HIL; Kuijf ML
Parkinsonism Relat Disord; 2019 May; 62():16-27. PubMed ID: 30580907
[TBL] [Abstract][Full Text] [Related]
13. Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.
Schrag A; Siddiqui UF; Anastasiou Z; Weintraub D; Schott JM
Lancet Neurol; 2017 Jan; 16(1):66-75. PubMed ID: 27866858
[TBL] [Abstract][Full Text] [Related]
14. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
[TBL] [Abstract][Full Text] [Related]
15. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
[TBL] [Abstract][Full Text] [Related]
16. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
[TBL] [Abstract][Full Text] [Related]
17. L-Theanine alleviates MPTP-induced Parkinson's disease by targeting Wnt/β-catenin signaling mediated by the MAPK signaling pathway.
Ratih K; Lee YR; Chung KH; Song DH; Lee KJ; Kim DH; An JH
Int J Biol Macromol; 2023 Jan; 226():90-101. PubMed ID: 36502788
[TBL] [Abstract][Full Text] [Related]
18. Decoupling of Global Brain Activity and Cerebrospinal Fluid Flow in Parkinson's Disease Cognitive Decline.
Han F; Brown GL; Zhu Y; Belkin-Rosen AE; Lewis MM; Du G; Gu Y; Eslinger PJ; Mailman RB; Huang X; Liu X
Mov Disord; 2021 Sep; 36(9):2066-2076. PubMed ID: 33998068
[TBL] [Abstract][Full Text] [Related]
19. Intranasal insulin ameliorates cognitive impairment in a rat model of Parkinson's disease through Akt/GSK3β signaling pathway.
Yang L; Zhang X; Li S; Wang H; Zhang X; Liu L; Xie A
Life Sci; 2020 Oct; 259():118159. PubMed ID: 32763288
[TBL] [Abstract][Full Text] [Related]
20. Contribution of language studies to the understanding of cognitive impairment and its progression over time in Parkinson's disease.
Auclair-Ouellet N; Lieberman P; Monchi O
Neurosci Biobehav Rev; 2017 Sep; 80():657-672. PubMed ID: 28782623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
